PMID- 11055888
OWN - NLM
STAT- MEDLINE
DCOM- 20010215
LR  - 20191104
IS  - 0037-1963 (Print)
IS  - 0037-1963 (Linking)
VI  - 37
IP  - 3 Suppl 5
DP  - 2000 Jul
TI  - Risk assessment of venous thromboembolism in medical patients.
PG  - 3-6
AB  - Medical patients are at risk of venous thromboembolism (VTE). However, the extent 
      of the risk is not well characterized. Risk stratification is an important part 
      of effective thromboprophylactic management. The risks depend on the specific 
      clinical risk factors in individual patients and include age, immobility, and 
      prior history of VTE. Medical patient risk assessment models (RAMs) are not fully 
      developed, but a number of specific risk factors have been characterized. 
      Although at present prophylactic treatment is largely empirical, studies 
      evaluating the effects of higher-dose regimens in at-risk patients are ongoing. 
      Long-term prophylaxis may be of benefit to particular patient populations, 
      including those with congenital and acquired aberrations in hemostasis. Published 
      studies of low-molecular-weight heparins (LMWHs) show that these agents are at 
      least as effective as low-dose unfractionated heparin (UFH), with a trend towards 
      an improved safety profile. The results of ongoing studies will provide further 
      insight into the risk of VTE in this important patient group.
FAU - Harenberg, J
AU  - Harenberg J
AD  - Department of Internal Medicine, University of Heidelberg, Germany.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Semin Hematol
JT  - Seminars in hematology
JID - 0404514
RN  - 0 (Fibrinolytic Agents)
SB  - IM
MH  - Fibrinolytic Agents/adverse effects/therapeutic use
MH  - Humans
MH  - Neoplasms/complications
MH  - Risk Assessment
MH  - Thromboembolism/*etiology/prevention & control
MH  - Thrombophilia/complications
MH  - Venous Thrombosis/*etiology/prevention & control
RF  - 12
EDAT- 2000/10/31 11:00
MHDA- 2001/03/03 10:01
CRDT- 2000/10/31 11:00
PHST- 2000/10/31 11:00 [pubmed]
PHST- 2001/03/03 10:01 [medline]
PHST- 2000/10/31 11:00 [entrez]
AID - S0037-1963(00)90092-1 [pii]
AID - 10.1016/s0037-1963(00)90092-1 [doi]
PST - ppublish
SO  - Semin Hematol. 2000 Jul;37(3 Suppl 5):3-6. doi: 10.1016/s0037-1963(00)90092-1.